Ryuji Kubota, Ph.D.

Clinical Pharmacology & Pharmacokinetics, Project Management Department, Shionogi & Co., Ltd. Osaka, Japan, Japan

Poster(s):

• (530) Population Pharmacokinetic Analysis of Ensitrelvir, an Inhibitor of 3C-like (3CL) Protease of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) for patients with SARS-Cov-2 Infection
  Thursday, October 12, 2023

  12:15 PM – 1:30 PM US ET